Your browser doesn't support javascript.
loading
Asymmetric Cell Division and Tumor Heterogeneity.
Li, Zizhu; Zhang, Ying Yi; Zhang, Haomiao; Yang, Jiaxuan; Chen, Yongze; Lu, Hezhe.
Afiliación
  • Li Z; State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
  • Zhang YY; Institute for Stem Cell and Regeneration, Chinese Academy of Sciences, Beijing, China.
  • Zhang H; University of Chinese Academy of Sciences, Beijing, China.
  • Yang J; Centre for Systems Biology, Lunenfeld-Tanenbaum Research Institute, Mount Sinai Hospital, Toronto, ON, Canada.
  • Chen Y; School of Stomatology, Dalian Medical University, Dalian, China.
  • Lu H; State Key Laboratory of Membrane Biology, Institute of Zoology, Chinese Academy of Sciences, Beijing, China.
Front Cell Dev Biol ; 10: 938685, 2022.
Article en En | MEDLINE | ID: mdl-35859890
ABSTRACT
Asymmetric cell division (ACD) gives rise to two daughter cells with different fates after mitosis and is a fundamental process for generating cell diversity and for the maintenance of the stem cell population. The cancer stem cell (CSC) theory suggests that CSCs with dysregulated self-renewal and asymmetric cell division serve as a source of intra-tumoral heterogeneity. This heterogeneity complicates the diagnosis and treatment of cancer patients, because CSCs can give rise to aggressive clones that are metastatic and insensitive to multiple drugs, or to dormant tumor cells that are difficult to detect. Here, we review the regulatory mechanisms and biological significance of asymmetric division in tumor cells, with a focus on ACD-induced tumor heterogeneity in early tumorigenesis and cancer progression. We will also discuss how dissecting the relationship between ACD and cancer may help us find new approaches for combatting this heterogeneity.
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Idioma: En Revista: Front Cell Dev Biol Año: 2022 Tipo del documento: Article País de afiliación: China